← Evidence map

ReviewFrontiers in pharmacology2015

β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Anne-Florence Blandin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

64 papers cite itlatest 60 shown

2015
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26635609